Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Alivus Life Sciences Ltd

Alivus Life Sciences Ltd share price and stock overview

Alivus Life Sciences Ltd (NSE: ALIVUS, BSE: 543322) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE03Q201024 and a face value of Rs 2. As of 12 August 2026, it trades at Rs (1,393.60) with a market capitalisation of Rs 16865.73 crore. Figures are live and subject to change.

Alivus Life Sciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,393.60 19.10 (1.39%) upARrowC
As on: 12-Aug-2026 , 12:47 AM
Market Cap(₹Cr) 16865.73
Book Value(₹Cr) 271.41036
BSE Code : 543322 NSE Symbol : ALIVUS EPS(TTM) : 50.64 ISIN Demat : INE03Q201024 P/E(TTM) : 27.13 Face Value(₹) : 2 Div & Yield % : 0.36

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

06 Aug 26
Alivus Life Sciences recommends Rs 5.00 per share dividend at September 2026 meeting
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, will hold its Fifteenth Annual General Meeting on September 8, 2026, at 3:00 p.
31 Jul 26
Alivus Life Sciences standalone net profit rises 31.71% in the June 2026 quarter
Net profit of Alivus Life Sciences rose 31.71% to Rs 160.08 crore in the quarter ended June 2026 as against Rs 121.
30 Jul 26
Alivus Life Sciences’ board approved allotment of shares to employees exercising stock options
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) announced that its board of directors approved the allotment of 32,000 equity shares of Rs 2 face value each to eligible employees who exercised stock options under the ‘Employee Stock Option Scheme, 2021’, increasing the company's paid-up share capital from 12,27,39,448 equity shares aggregating to Rs 24,54,78,896 to 12,27,71,448 equity shares aggregating to Rs 24,55,42,896.
30 Jul 26
Alivus Life Sciences reports Rs 1,601 million net profit, revenue up 6.4% year-over-year
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, announced a net profit after tax of Rs 1,601 million for the first quarter ended June 30, 2026, a 31.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 1384.00 1418.00 1374.30 1393.60 188900 18264 263844070.60 24471.70
10-08-26 1339.40 1387.40 1336.40 1374.50 342674 28124 469197493.20 24583.80
07-08-26 1329.50 1345.00 1315.50 1329.80 85268 8847 113509036.50 24570.65
06-08-26 1329.90 1377.90 1312.60 1325.20 167654 15333 225409118.00 24636.00
05-08-26 1335.00 1338.60 1304.00 1331.00 163968 14595 216097836.80 24624.65
04-08-26 1225.00 1358.00 1201.20 1335.80 1241662 66388 1625685591.60 24614.90
03-08-26 1182.80 1225.00 1172.90 1214.40 199736 25069 241203654.80 24774.30
31-07-26 1135.50 1177.60 1108.00 1160.00 237291 21812 273764441.90 24383.60
30-07-26 1119.60 1142.90 1089.80 1095.70 53239 7276 59062869.80 24317.15
29-07-26 1119.00 1130.00 1104.40 1119.60 24416 3791 27297254.40 24250.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

16865.73

PE Ratio

27.13

PB Ratio

5.06

Dividend Yield

0.36

ROE

18.86

ROCE

24.97

Book Value (₹)

271.41036

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 91896285 74.87 91896285 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 91896285 74.87 91896285 1
Total ShareHolding for Promoter & Group 91896285 74.87 91896285 1
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6799677 5.54 6799677 68
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 333862 0.27 333862 1
Mutual Funds / UTI 6939496 5.65 6939496 14
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1541560 1.26 1541560 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15614595 12.72 15614595 97
plus  Non Institution
Bodies Corporate 1552820 1.27 1552820 854
Clearing Members 685 0.00 685 3
Directors & their Relatives 157600 0.13 157600 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 841882 0.69 841882 2966
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 303592 0.25 303592 2484
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 918073 0.75 918073 5
Individuals holding nominal share capital up to Rs. 1 lakh 11415877 9.30 11415877 119139
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 38039 0.03 38039 7
Others 0 0.00 0 0
Sub Total 15228568 12.41 15228568 125461
Total Public Shareholding 30843163 25.13 30843163 125558
Total of Promoter & Public ShareHolding 122739448 100.00 122739448 125559
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 122739448 100.00 122739448 125559

Financials (₹ in cr)

Consolidated Standalone

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital 24.5124.5124.5124.511.961.96
Reserves Total 2792.872307.822113.702029.81750.79399.73
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2817.382332.332138.212054.32752.75401.69
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 56.6117.1519.362.880.000.02
Total Debt56.6117.1519.362.880.000.02
Other Liabilities18.5415.777.870.000.000.00
Total Liabilities2892.532365.252165.442057.20752.75401.71
APPLICATION OF FUNDS :
Gross Block 1218.711012.33936.48710.80651.90594.82
Less : Accumulated Depreciation 263.76207.26155.85115.7779.1048.58
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 954.95805.07780.63595.03572.80546.24
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress101.91105.9961.6291.6914.1010.73
Producing Properties0.000.000.000.000.000.00
Investments 477.690.080.080.080.080.08
Current Assets, Loans & Advances
Inventories 673.95666.59604.17516.24513.42412.78
Sundry Debtors 969.74765.43806.77673.49619.50638.63
Cash and Bank Balance71.24301.59309.40512.16115.6010.00
Loans and Advances 142.62182.38130.0162.69150.5298.71
Total Current Assets1857.541916.001850.341764.591399.041160.12
Less : Current Liabilities and Provisions
Current Liabilities 447.56424.35479.53355.881187.851285.10
Provisions 16.9612.0314.7526.4433.6022.34
Total Current Liabilities & Provisions464.52436.38494.28382.321221.441307.44
Net Current Assets1393.021479.621356.071382.27177.59-147.33
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets7.324.551.811.072.030.13
Deferred Tax Liability61.7453.3444.2532.5724.9116.58
Net Deferred Tax-54.42-48.79-42.44-31.50-22.88-16.45
Other Assets19.3623.299.4919.6311.068.44
Total Assets2892.512365.252165.452057.20752.75401.72
Contingent Liabilities4.824.822.222.222.222.22

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Financing Activities -213.78-78.80-387.59-279.44-6.23
Investing Activities -68.73-122.23-146.75-116.48-615.65
Net Cash Flow 105.60396.56-228.3317.59-230.35
Operating Activities 388.11597.59306.01413.52391.52

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
HKP
HIREN KARSANBHAI PATEL
Chairman & Independent Directo
Executive
Functional Directors
YYR
Yasir Yusufali Rawjee
Managing Director & CEO
MD
Independent Directors
KNP
KAUSHIKBHAI NANDUBHAI PATEL
Independent Non Exe. Director
Ind.
MA
Manju Agarwal
Independent Non Exe. Director
Ind.
TLE
Taruvai Laxminarayanan Easwar
Independent Non Exe. Director
Ind.
SG
Savan Godialwala
Independent Non Exe. Director
Ind.
Other Officials
VN
Vinod Naik
ED / WTD / Head - Technical & Operations
Board
RC
Rudalf Corriea
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Alivus Life Sciences Ltd? −

Alivus Life Sciences Ltd trades on NSE under ALIVUS and on BSE under code 543322. The ISIN is INE03Q201024 and the face value is Rs 2.

What is the share price of Alivus Life Sciences Ltd today? +

As of 12 August 2026, Alivus Life Sciences Ltd trades at Rs 1,393.60, a change of 19.10 (1.39%) on the day. Prices are live and subject to change.

What is the market capitalisation of Alivus Life Sciences Ltd? +

As of 12 August 2026, Alivus Life Sciences Ltd has a market cap of about Rs 16865.73 crore. This figure is live and moves with the share price.

Is Alivus Life Sciences Ltd profitable? +

In , Alivus Life Sciences Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Alivus Life Sciences Ltd? +

: As of 12 August 2026, the PE (TTM) for Alivus Life Sciences Ltd is 27.13 and the price-to-book ratio is 5.06. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Alivus Life Sciences Ltd pay a dividend? +

As of 12 August 2026, the dividend yield for Alivus Life Sciences Ltd is 0.36%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Alivus Life Sciences Ltd? +

As of the latest disclosed pattern, promoters hold 74.87% of Alivus Life Sciences Ltd. Public shareholding is 25.13%, including mutual funds at 5.65% and foreign institutional investors at 5.54%.

What were the latest annual financials of Alivus Life Sciences Ltd? +

In , Alivus Life Sciences Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web